Article
Once-daily regimen may effectively lower IOP
Sarasota, FL-Data from three clinical trials show that Travatan/Timolol Fixed Combination (TTFC), Alcon's investigational new drug to treat glaucoma, is a safe alternative to the two single compounds dosed concomitantly, the company says.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
